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The editorial group responsible for this previously published document have withdrawn it from publication.
R E A S O N F O R W I T H D R A W A L
This protocol is being withdrawn because it is out of date.
W H A T ’ S N E W
Date Event Description
4 June 2019 Amended This protocol is being withdrawn
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